Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Gupta is currently an Oncology Fellow at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

For information on Dr. Gupta see the following links - 

Hopkins Medicine Kimmel Cancer Center

ASCO

Supportive Care Video Series: Pancreatic Enzyme Replacement Therapy, or PERT
Author
Arjun Gupta, MD, Advisory Board Member, GRACE Faculty
Image
GRACE is very excited to bring to you more videos from our program, Supportive Care in Cancer Treatment.

Arjun Gupta, MD is the host of this video series, Supportive Care in Cancer Treatment. In this video, Dr. Gupta speaks with Christi M. Walsh, MSN, CRNP, with Johns Hopkins University in Baltimore, MD.

Christi Walsh and Dr. Gupta discuss Pancreatic Enzyme Replacement Therapy, or PERT.

For more information on PERT, please visit https://www.pancan.org/facing-pancreatic-cancer/living-with-pancreatic-cancer/diet-and-nutrition/pancreatic-enzymes/


 

 
A huge thankyou to our sponsors who have made this series possible! 

 

 

To join the conversation, visit https://cancergrace.org/forum.

To find additional CancerGRACE resources, visit https://cancergrace.org.

To donate to CancerGRACE, visit https://cancergrace.org/donate.

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.